Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BAROnova Inc.

www.baronova.com

Latest From BAROnova Inc.

BaroNova’s TransPyloric Shuttle Earns FDA-Approval To Treat Obesity

Patients treated with the TransPyloric Shuttle in the 213-patient ENDObesity II trial lost an average of 9.5% of their body-weight and 30.9% of their excess weight.

Approvals Clinical Trials

Market Intel: Intragastric Balloons And Other Innovations To Inflate Weight Loss Devices Market

The global market for minimally invasive weight loss devices is expected to grow to $290m by 2021, a CAGR of 16%, driven in large part by the rising obesity epidemic and associated Type 2 diabetes. Meddevicetracker expects that enhancements and innovations, particularly in the growing intragastric balloon market, and emerging technologies by smaller companies, will lead the growth in the overall weight loss devices market. In this feature, we'll take a closer look at the overall market and regional landscape and take a deep dive into the fastest-growing intragastric balloon segment, providing key insights from a bariatric surgeon on the pros and cons of these technologies.

Analysis Commercial

Medtech Execs On The Move, June 2016

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Execs On The Move, June 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • BAROnova Inc.
  • Senior Management
  • David S Thrower, Pres. & CEO
    Kobi Iki, VP, R&D
  • Contact Info
  • BAROnova Inc.
    Phone: (805) 681-7000
    281 Magnolia Ave., Ste. 300
    Goleta, CA 93117
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register